Clover Health Investments Quarterly Cash Flow Statement
NASDAQ: CLOVHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Clover Health Investments free cash flow
In the quarter ended Jun 30, 2026, Clover Health Investments generated $25.2 million of operating cash flow and spent $682,000 on capital expenditures. That left free cash flow of $24.5 million, a free-cash-flow margin of 3.3% of revenue. Free cash flow was up 406.4% from the prior year's $4.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
Clover Health Investments cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 28.00M | 27.33M | -49.32M | -24.38M | -10.58M | -1.27M | -22.09M | -9.15M | 7.41M | -19.17M | -70.47M | -41.47M |
| Net Income growth (YoY) | — | — | — | — | -242.79% | — | — | — | — | — | — | — |
| Depreciation & Amortization | -428.00K | -441.00K | -501.00K | -396.00K | -509.00K | -437.00K | -384.00K | -522.00K | -947.00K | -671.00K | -918.00K | -1.24M |
| Stock-Based Compensation | 9.08M | 12.27M | 24.92M | 26.11M | 26.20M | 26.44M | 29.64M | 27.99M | 27.90M | 28.80M | 33.14M | 33.07M |
| Change in Working Capital | -53.00K | 10.62M | -29.12M | -20.43M | 9.10M | -7.15M | -2.36M | 21.23M | 25.11M | -34.20M | -106.78M | -13.29M |
| Operating Cash Flow | 25.19M | 107.89M | -68.15M | 12.10M | 5.41M | -16.29M | -85.83M | 49.99M | 44.76M | 25.93M | -258.09M | -18.78M |
| Capital Expenditures | -682.00K | -854.00K | -597.00K | -692.00K | -569.00K | -185.00K | -315.00K | -399.00K | -397.00K | -445.00K | 264.00K | -243.00K |
| Investing Cash Flow | -32.00K | -5.07M | -34.99M | -5.42M | 35.57M | 8.93M | -1.44M | -12.13M | 4.95M | 9.19M | 83.66M | -20.32M |
| Share Repurchases | 0 | 0 | 0 | -1.00K | 0 | -18.30M | 0 | 0 | -1.77M | 0 | 0 | 0 |
| Financing Cash Flow | 416.00K | -7.86M | -8.61M | -5.27M | -7.76M | -31.74M | -6.14M | -4.67M | -3.19M | -3.36M | -826.00K | -1.96M |
| Net Change in Cash | 25.57M | 94.96M | -111.75M | 1.41M | 33.21M | -39.10M | -93.41M | 33.19M | 46.52M | 31.76M | -175.25M | -41.06M |
| Free Cash Flow | 24.51M | 107.04M | -68.75M | 11.41M | 4.84M | -16.48M | -86.15M | 49.59M | 44.36M | 25.49M | -257.82M | -19.02M |
This table shows 12 quarterly periods of Clover Health Investments's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CLOV's reporting calendar. What is a cash flow statement?